{"id":"NCT00545077","sponsor":"Spanish Breast Cancer Research Group","briefTitle":"Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women","officialTitle":"Multicenter, Randomized Trial to Evaluate Efficacy and Safety of Bevacizumab in Combination With Endocrine Treatment vs Endocrine Alone, in Postmenopausal With Advanced or Metastatic Cancer With Indication of Hormonotherapy as First-line","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11-06","primaryCompletion":"2013-12","completion":"2014-07-24","firstPosted":"2007-10-17","resultsPosted":"2019-07-10","lastUpdate":"2023-03-31"},"enrollment":380,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Letrozole","otherNames":["Femara"]},{"type":"DRUG","name":"Bevacizumab","otherNames":["Avastin"]},{"type":"DRUG","name":"Fulvestrant","otherNames":["Faslodex"]}],"arms":[{"label":"Arm A: Endocrine Therapy (ET)","type":"ACTIVE_COMPARATOR"},{"label":"Arm B: ET with Bevacizumab (ET-B)","type":"EXPERIMENTAL"}],"summary":"Locally advanced or metastatic breast cancer in postmenopausal women with negative Human Epidermal Growth Factor Receptor 2 (HER2), who are candidates for hormone treatment and who have not received previous chemotherapy or hormonotherapy for the metastatic disease.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"Up to 2 years","effectByArm":[{"arm":"Arm A: Endocrine Therapy (ET)","deltaMin":14.4,"sd":null},{"arm":"Arm B: ET With Bevacizumab (ET-B)","deltaMin":19.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":70,"countries":["Germany","Spain"]},"refs":{"pmids":["25691671","31276981","34218359"],"seeAlso":["http://www.geicam.org/"]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":184},"commonTop":["Anemia","Pain","Elevated liver enzyme (ALT and/or AST)","Fatigue","Hypertension"]}}